Clinical Scorecard: Comprehensive Analysis of Digital Biomarkers Indicating Fatigue in Chronic Illnesses
At a Glance
Category
Detail
Condition
Fatigue in chronic diseases including MS, RA, COPD, long COVID, cancer, CFS, and others
Key Mechanisms
Reduced physical activity, increased sedentary behavior, autonomic dysfunction measured via wearable digital biomarkers
Target Population
Patients with chronic diseases experiencing fatigue
Care Setting
Outpatient and home-based settings utilizing wearable digital health devices
Key Highlights
Fatigue is a prevalent, debilitating symptom across multiple chronic diseases, affecting quality of life and daily functioning.
Wearable devices provide objective, continuous digital biomarkers such as physical activity levels and physiological signals that correlate with fatigue.
Digital biomarkers complement self-reported fatigue measures and enable personalized fatigue management strategies.
Guideline-Based Recommendations
Diagnosis
Incorporate wearable digital devices to objectively measure physical activity and physiological parameters related to fatigue.
Combine digital biomarker data with self-reported fatigue assessments for comprehensive evaluation.
Management
Use digital biomarker trends to inform personalized interventions targeting physical activity and sedentary behavior.
Leverage remote monitoring to adjust fatigue management plans dynamically.
Monitoring & Follow-up
Implement longitudinal tracking of digital biomarkers via wearable devices to monitor fatigue progression and treatment response.
Utilize real-time data to facilitate timely clinical decision-making.
Risks
Be aware of variability in digital biomarker-fatigue associations across different chronic diseases.
Consider device adherence and data quality limitations in interpretation.
Patient & Prescribing Data
5573 participants across 15 chronic disease domains including MS, cancer, long COVID, COPD, CFS, RA, Parkinson’s, and others.
Digital biomarkers such as physical activity levels and autonomic function correlate with fatigue severity and can guide personalized fatigue management.
Clinical Best Practices
Utilize non-invasive wearable devices for continuous, home-based fatigue monitoring.
Integrate objective digital biomarker data with subjective fatigue reports for holistic assessment.
Tailor fatigue interventions based on disease-specific digital biomarker profiles.
Ensure patient education on device use to optimize data reliability.
Regularly review digital biomarker trends to adjust clinical management.
